Home » Topics » Regulatory » Patents

Patents
RSS

Assembly Biosciences synthesizes new HBV antivirals

Nov. 15, 2021

Janssen Pharmaceutica identifies NLRP3 inflammasome inhibitors

Nov. 15, 2021

Tenova Pharmaceuticals discloses EGFR and/or ALK inhibitors

Nov. 15, 2021

Heptares Therapeutics patents histamine H4 receptor antagonists

Nov. 15, 2021

Jmackem divulges new TRPV1 antagonists

Nov. 15, 2021

BioWorld MedTech Patent Highlights: Week 44

From Current Patent Gazette

Nov. 12, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Boehringer Ingelheim presents new HER2 inhibitors

Nov. 12, 2021

New compounds inhibiting respiratory syncytial virus identified at Janssen

Nov. 12, 2021

Roche patents potassium voltage-gated channel subfamily C member 1 activators

Nov. 12, 2021

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Nov. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...